Cleared Traditional

TheraFace Microcurrent (K212238) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212238 · Theragun, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
72d
Days
Class 2
Risk

K212238 is an FDA 510(k) clearance for the TheraFace Microcurrent. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Theragun, Inc. (Los Angeles, US). The FDA issued a Cleared decision on September 29, 2021 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Theragun, Inc. devices

Submission Details

510(k) Number K212238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2021
Decision Date September 29, 2021
Days to Decision 72 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 148d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Schiff & Company, Inc.
Thomas Padula

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K212238.
PureLift Pro Plus
K221443 · Xtreem Pulse, LLC · Oct 2022
Luminice
K214100 · Premier North America, Inc. · Feb 2022
Microcurrent device (Model: HBR2-1)
K211055 · Shenzhen DJ Medical Equipment Co., Ltd. · Nov 2021
ZIIP+ Device
K212342 · Ziip, Inc. · Sep 2021
Avazzia OTC TENS for aesthetics, model BEST-AV1™: EZZI-LIFT™ Device
K191951 · Avazzia, Inc. · Apr 2021
Trinity ELE Plus and Trinity ELE Plus Pro
K201906 · Carol Cole Company Dba Nuface · Feb 2021